吉非替尼PLGA微球的制备与体外释放研究

    The preparation and release of Gefitnib PLGA microsphere in vitro

    • 摘要: 目的: 以吉非替尼为模型药物,乳酸-羟基乙酸共聚物(PLGA)为载体,研究制备吉非替尼PLGA缓释微球.方法: 选择O/W乳化溶剂扩散法制备微球,在单因素考察的基础上,设计正交试验优化制备工艺;采用光学显微镜、扫描电镜等手段观察微球形貌;差式扫描量热法验证吉非替尼PLGA微球的形成;考察吉非替尼PLGA微球的体外释放行为.结果: 差式扫描量热法结果表明,吉非替尼与PLGA分子间作用力发生变化,以分子形式均匀分散在载体中.吉非替尼PLGA微球呈白色球形颗粒,表面平整,平均粒径为(10.35±0.32)μm,包封率为(88.44±1.26)%,载药率为(10.00±0.23)%;体外释药符合零级释放方程Q=0.769t-1.800 9,r2=0.980 8.结论: 吉非替尼PLGA微球制备工艺稳定,在体外缓慢释放药物达5 d以上,具有明显的缓释作用.

       

      Abstract: Objective: To explore the preparation of Gefitnib(PLGA) delayed-release microspheres based on Gefitnib for medol drug and PLGA for carrier.Methods: The microspheres were prepared using the O/W emulsification-solvents diffusion technique,the preparation technology was optimized by orthogonal design based on single factor experiment.The appearance of Gefitnib microsphere was observed by optical microscope and scanning electron microscope,the formation of PLGA microsphere was indentified by DSC,the release of Gefitnib PLGA microsphere was observed in vitro.Results: The results of DSC showed that the intermolecular force of Gefitnib and PLGA changed,Gefitnib evenly dispersed in carrier in the form of molecular.Gefitnib PLGA microsphere was white and smooth sphere,the mean particle size,encapsulate efficiency and drug loading of which were(10.35±0.32)μm,(88.44±1.26)% and(10.00±0.23)%,respectively.The release behavior of Gefitnib PLGA microsphere in vitro followed the zero order equation,Q=0.769t-1.800 9,r2=0.980 8.Conclusions: The preparation technique of Gefitnib PLGA microsphere is stable,the release of drug in vitro of which is more than 5 d,and it has obvious sustained release effect.

       

    /

    返回文章
    返回